274 related articles for article (PubMed ID: 28391556)
1. Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Wozniak KM; Kulesh B; Savage A; Slusher BS; Littlefield BA; Jordan MA; Wilson L; Feinstein SC
Neurotox Res; 2017 Jul; 32(1):151-162. PubMed ID: 28391556
[TBL] [Abstract][Full Text] [Related]
2. Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Cook BM; Reifert J; Wozniak KM; Slusher BS; Littlefield BA; Wilson L; Jordan MA; Feinstein SC
Neurotox Res; 2016 Feb; 29(2):299-313. PubMed ID: 26659667
[TBL] [Abstract][Full Text] [Related]
3. Differential Morphological and Biochemical Recovery from Chemotherapy-Induced Peripheral Neuropathy Following Paclitaxel, Ixabepilone, or Eribulin Treatment in Mouse Sciatic Nerves.
Cook BM; Wozniak KM; Proctor DA; Bromberg RB; Wu Y; Slusher BS; Littlefield BA; Jordan MA; Wilson L; Feinstein SC
Neurotox Res; 2018 Oct; 34(3):677-692. PubMed ID: 30051419
[TBL] [Abstract][Full Text] [Related]
4. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
LaPointe NE; Morfini G; Brady ST; Feinstein SC; Wilson L; Jordan MA
Neurotoxicology; 2013 Jul; 37():231-9. PubMed ID: 23711742
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.
Wozniak KM; Nomoto K; Lapidus RG; Wu Y; Carozzi V; Cavaletti G; Hayakawa K; Hosokawa S; Towle MJ; Littlefield BA; Slusher BS
Cancer Res; 2011 Jun; 71(11):3952-62. PubMed ID: 21498637
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs.
Smith JA; Slusher BS; Wozniak KM; Farah MH; Smiyun G; Wilson L; Feinstein S; Jordan MA
Cancer Res; 2016 Sep; 76(17):5115-23. PubMed ID: 27488522
[TBL] [Abstract][Full Text] [Related]
7. Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
Wozniak KM; Vornov JJ; Wu Y; Nomoto K; Littlefield BA; DesJardins C; Yu Y; Lai G; Reyderman L; Wong N; Slusher BS
Cancer Res; 2016 Jun; 76(11):3332-9. PubMed ID: 27197173
[TBL] [Abstract][Full Text] [Related]
8. Clinical and preclinical features of eribulin-related peripheral neuropathy.
Tarasiuk O; Cavaletti G; Meregalli C
Exp Neurol; 2022 Feb; 348():113925. PubMed ID: 34801586
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
Wozniak KM; Vornov JJ; Wu Y; Liu Y; Carozzi VA; Rodriguez-Menendez V; Ballarini E; Alberti P; Pozzi E; Semperboni S; Cook BM; Littlefield BA; Nomoto K; Condon K; Eckley S; DesJardins C; Wilson L; Jordan MA; Feinstein SC; Cavaletti G; Polydefkis M; Slusher BS
Cancer Res; 2018 Feb; 78(3):817-829. PubMed ID: 29191802
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.
Pittman SK; Gracias NG; Fehrenbacher JC
Exp Neurol; 2016 May; 279():104-115. PubMed ID: 26883566
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects.
Gornstein EL; Schwarz TL
Exp Neurol; 2017 Feb; 288():153-166. PubMed ID: 27894788
[TBL] [Abstract][Full Text] [Related]
12. Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics.
Guo L; Hamre J; Eldridge S; Behrsing HP; Cutuli FM; Mussio J; Davis M
Toxicol Sci; 2017 Mar; 156(1):275-288. PubMed ID: 28115644
[TBL] [Abstract][Full Text] [Related]
13. Assessing the utility of in vitro microtubule assays for studying mechanisms of peripheral neuropathy with the microtubule inhibitor class of cancer chemotherapy.
Genualdi C; Feinstein SC; Wilson L; Jordan MA; Stagg NJ
Chem Biol Interact; 2020 Jan; 315():108906. PubMed ID: 31760042
[TBL] [Abstract][Full Text] [Related]
14. Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the βIII tubulin isotype.
Wilson L; Lopus M; Miller HP; Azarenko O; Riffle S; Smith JA; Jordan MA
Biochemistry; 2015 Oct; 54(42):6482-9. PubMed ID: 26435331
[TBL] [Abstract][Full Text] [Related]
15. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy.
Wozniak KM; Wu Y; Farah MH; Littlefield BA; Nomoto K; Slusher BS
Neurotox Res; 2013 Oct; 24(3):338-44. PubMed ID: 23637052
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel causes degeneration of both central and peripheral axon branches of dorsal root ganglia in mice.
Tasnim A; Rammelkamp Z; Slusher AB; Wozniak K; Slusher BS; Farah MH
BMC Neurosci; 2016 Jul; 17(1):47. PubMed ID: 27401104
[TBL] [Abstract][Full Text] [Related]
18. Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA.
Fermaintt CS; Takahashi-Ruiz L; Liang H; Mooberry SL; Risinger AL
Mol Pharmacol; 2021 Oct; 100(4):309-318. PubMed ID: 34312217
[TBL] [Abstract][Full Text] [Related]
19. Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent.
Dybdal-Hargreaves NF; Risinger AL; Mooberry SL
Clin Cancer Res; 2015 Jun; 21(11):2445-52. PubMed ID: 25838395
[TBL] [Abstract][Full Text] [Related]
20. The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner.
Hüsemann LC; Reese A; Radine C; Piekorz RP; Budach W; Sohn D; Jänicke RU
Cell Cycle; 2020 Feb; 19(4):464-478. PubMed ID: 31959066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
